Identifying and targeting mechanisms of lung cancer initiation
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210421
- Recipient
-
Sloan-Kettering Institute For Cancer Research UEI KUKXRCZ6NZC2
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $619,500
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- New York, NY 10065, USA
Award details come from USAspending.gov.
About this award
The Sloan-Kettering Institute For Cancer Research was awarded a $619,500 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The two-year award will fund research to identify and target mechanisms of lung cancer initiation. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield injuries and other health issues. This award will advance those goals by furthering scientific understanding of lung cancer development, which could enable new diagnostic and therapeutic approaches to benefit both military personnel and civilians.
Quick answers
Who received award W81XWH2210421?
W81XWH2210421 was awarded to Sloan-Kettering Institute For Cancer Research by Medical Command (Department of the Army) on June 1, 2022.
How much is award W81XWH2210421 worth?
$619,500 has been obligated on W81XWH2210421.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award